Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC KRAS G12D inhibitor 5mg | 2757095-12-6 | 748.11 g/mol | C36H32ClF6N5O4 | 5 MG
SDP

Catalog No. 5000307822
Encompass_Preferred

KRAS G12D inhibitor 3 TFA is a small-molecule trifluoroacetate salt developed for preclinical research targeting the KRAS G12D mutation. Supplied in milligram quantities, the compound is characterized by analytical data to support experimental use.

  • High purity suitable for research use
  • Provided as a trifluoroacetate (TFA) salt
  • Analytical characterization available: COA, NMR, HPLC, LCMS
  • Intended for preclinical cancer and cellular studies
  • Offered in low-milligram quantities for assay development

Catalog No. 50-003-07822 Supplier Medchemexpress LLC Supplier No. HY115880A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

KRAS G12D inhibitor 3 TFA is a small-molecule trifluoroacetate salt developed for preclinical research targeting the KRAS G12D mutation. Supplied in milligram quantities, the compound is characterized by analytical data to support experimental use.

  • High purity suitable for research use
  • Provided as a trifluoroacetate (TFA) salt
  • Analytical characterization available: COA, NMR, HPLC, LCMS
  • Intended for preclinical cancer and cellular studies
  • Offered in low-milligram quantities for assay development

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.